• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India.对提交给印度中部一家三级护理教学机构伦理委员会的临床试验协议和保险政策的分析。
Perspect Clin Res. 2022 Jul-Sep;13(3):151-154. doi: 10.4103/picr.PICR_124_20. Epub 2021 Mar 26.
2
Review of policies for injuries to research participants in India.印度研究参与者伤害政策综述。
J Med Ethics. 2009 Feb;35(2):133-9. doi: 10.1136/jme.2008.025155.
3
A study to assess completeness of project application forms submitted to Institutional Ethics Committees (IEC) of a tertiary care hospital.一项评估提交给三级医院机构伦理委员会(IEC)的项目申请表完整性的研究。
Perspect Clin Res. 2012 Oct;3(4):133-8. doi: 10.4103/2229-3485.103594.
4
A Study of Assessing Errors and Completeness of Research Application Forms Submitted to Instituitional Ethics Committee (IEC) of a Tertiary Care Hospital.一项关于评估提交给三级医疗机构伦理委员会(IEC)的研究申请表的错误与完整性的研究。
J Clin Diagn Res. 2016 Sep;10(9):FC10-FC12. doi: 10.7860/JCDR/2016/18393.8488. Epub 2016 Sep 1.
5
Insurance in clinical research.临床研究中的保险。
Perspect Clin Res. 2014 Oct;5(4):145-50. doi: 10.4103/2229-3485.140541.
6
Analysis of the compliance of informed consent documents with good clinical practice guideline.知情同意文件符合良好临床实践规范的分析。
Contemp Clin Trials. 2011 Sep;32(5):662-6. doi: 10.1016/j.cct.2011.05.016. Epub 2011 Jun 2.
7
Informed Consent Documents submitted for initial review: what do they state about compensation for injured research participants?提交进行初审的知情同意书:它们对受伤研究参与者的补偿是如何说明的?
Indian J Med Sci. 2009 Oct;63(10):455-60.
8
American Society of Clinical Oncology policy statement: oversight of clinical research.美国临床肿瘤学会政策声明:临床研究监督
J Clin Oncol. 2003 Jun 15;21(12):2377-86. doi: 10.1200/JCO.2003.04.026. Epub 2003 Apr 29.
9
Analysis of serious adverse events reports: Review by an Institutional Ethics Committee of a tertiary care teaching hospital.严重不良事件报告分析:一家三级护理教学医院的机构伦理委员会审查
Perspect Clin Res. 2022 Oct-Dec;13(4):189-193. doi: 10.4103/picr.PICR_293_20. Epub 2021 Jul 12.
10
Payment for participation in clinical research: Review of proposals submitted to the ethics committees.参与临床研究的报酬:提交给伦理委员会的提案审查
Perspect Clin Res. 2018 Apr-Jun;9(2):64-69. doi: 10.4103/picr.PICR_159_16.

引用本文的文献

1
Clinical trial agreements and insurance policies - role of the EC.临床试验协议与保险政策——伦理委员会的作用
Perspect Clin Res. 2022 Jul-Sep;13(3):121-122. doi: 10.4103/picr.picr_271_21. Epub 2022 Jun 30.

本文引用的文献

1
Knowledge about clinical trial agreement and clinical trial related insurance among Ethics Committee members: A cross-sectional survey.伦理委员会成员对临床试验协议和临床试验相关保险的认知:一项横断面调查。
Perspect Clin Res. 2016 Oct-Dec;7(4):191-192. doi: 10.4103/2229-3485.192048.
2
Insurance in clinical research.临床研究中的保险。
Perspect Clin Res. 2014 Oct;5(4):145-50. doi: 10.4103/2229-3485.140541.
3
Injury and death in clinical trials and compensation: Rule 122 DAB.临床试验中的伤害与死亡及赔偿:第122条争端上诉委员会规则
Perspect Clin Res. 2013 Oct;4(4):199-203. doi: 10.4103/2229-3485.120167.
4
Compensation for research related injury.对研究相关损伤的补偿。
Perspect Clin Res. 2013 Jan;4(1):61-9. doi: 10.4103/2229-3485.106392.
5
A study to assess completeness of project application forms submitted to Institutional Ethics Committees (IEC) of a tertiary care hospital.一项评估提交给三级医院机构伦理委员会(IEC)的项目申请表完整性的研究。
Perspect Clin Res. 2012 Oct;3(4):133-8. doi: 10.4103/2229-3485.103594.
6
U. S. Health Researchers Review their Ethics Review Boards: A Qualitative Study.美国健康研究人员审视其伦理审查委员会:一项定性研究
J Empir Res Hum Res Ethics. 2006 Jun;1(2):39-58. doi: 10.1525/jer.2006.1.2.39.
7
Centralized and non-centralized ethics review: a five nation study.集中式与非集中式伦理审查:一项五国研究。
Account Res. 2006 Jan-Mar;13(1):47-74. doi: 10.1080/08989620600588944.
8
The compensation of patients injured in clinical trials.临床试验中受伤害患者的补偿。
J Med Ethics. 1995 Jun;21(3):166-9. doi: 10.1136/jme.21.3.166.

对提交给印度中部一家三级护理教学机构伦理委员会的临床试验协议和保险政策的分析。

Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India.

作者信息

Kalikar Mrunalini V, Dakhale Ganesh N, Sinha Vishakha V, Giradkar Akhil B

机构信息

Department of Pharmacology, Government Medical College, Nagpur, Maharashtra, India.

Department of Pharmacology, All India Institute of Medical Sciences, Nagpur, Maharashtra, India.

出版信息

Perspect Clin Res. 2022 Jul-Sep;13(3):151-154. doi: 10.4103/picr.PICR_124_20. Epub 2021 Mar 26.

DOI:10.4103/picr.PICR_124_20
PMID:35928639
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9345254/
Abstract

PURPOSE

Very few studies conducted in India have analyzed insurance policies and clinical trial agreement (CTA) submitted to ethics committee (EC). This study was conducted to review and find out deficiencies in it.

MATERIALS AND METHODS

This was a retrospective observational study. All the protocols for regulatory clinical trials and academic research sponsored by the Indian Council of Medical Research or other funding agency were included. Insurance documents and CTA submitted with the study protocols were analyzed.

RESULTS

A total of seventy CTA and insurance policies were analyzed. CTA mentioned that parties involved in 60 (86%) forms, scope of the agreement in 15 (21%) forms, responsibilities of the party in 68 (97%) forms, and payment details in 58 (83%) forms. Nearly 88.5% of the insurance policies mentioned whether the policy covers the participants for injury due to all clauses and 91% of the policies mentioned the validity period of insurance.

CONCLUSION

It was found that both the documents contained almost all the required elements. This was probably because this institutional EC insisted on and thoroughly reviewed the documents to ensure that adequate compensation of research-related injuries has been provided for and this fact is informed to the trial subject. As very few studies are available in the literature, we could not compare majority of the findings of this study with others.

摘要

目的

在印度开展的研究中,极少有对提交给伦理委员会(EC)的保险政策和临床试验协议(CTA)进行分析的。本研究旨在对此进行审查并找出其中的不足之处。

材料与方法

这是一项回顾性观察研究。纳入了由印度医学研究理事会或其他资助机构赞助的所有监管临床试验和学术研究的方案。对随研究方案提交的保险文件和CTA进行了分析。

结果

共分析了70份CTA和保险政策。CTA中提及参与方的有60份(86%),协议范围的有15份(21%),参与方责任的有68份(97%),支付细节的有58份(83%)。近88.5%的保险政策提及该政策是否涵盖所有条款导致的参与者伤害,91%的政策提及了保险有效期。

结论

发现这两份文件几乎包含了所有必需的要素。这可能是因为该机构伦理委员会坚持并彻底审查了这些文件,以确保为与研究相关的伤害提供了充分补偿,并将这一情况告知试验对象。由于文献中相关研究极少,我们无法将本研究的大部分结果与其他研究进行比较。